[Increase of the membrane-bound urokinase level in monocytes from patients with atherosclerosis is accompanied by decrease of urokinase-induced myocyte migration].
Arefieva
T I
TI
Krasnikova
T L
TL
Parfenova
E V
EV
Alekseeva
I A
IA
D001161:Arteriosclerosis / Q000097:blood*; D002462:Cell Membrane / Q000201:enzymology / Q000378:metabolism; D002630:Chemotactic Factors / Q000494:pharmacology; D002634:Chemotaxis, Leukocyte / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D016177:Macrophage-1 Antigen / Q000378:metabolism; D009000:Monocytes / Q000201:enzymology* / Q000502:physiology* / Q000648:ultrastructure; D011956:Receptors, Cell Surface / Q000378:metabolism; D055293:Receptors, Urokinase Plasminogen Activator; D011994:Recombinant Proteins / Q000494:pharmacology; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism* / Q000494:pharmacology
D002630:Chemotactic Factors; D016177:Macrophage-1 Antigen; C524898:PLAUR protein, human; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D011994:Recombinant Proteins; D014568:Urokinase-Type Plasminogen Activator; C067551:saruplase
Uvelichenie kolichestva membranno-sviazannoĭ urokinazy na monotsitakh bol'nykh aterosklerozom soprovozhdaetsia snizheniem urokinazoindutsirovannoĭ migratsii monotsitov.